Sofia, Bulgaria, December 29, 2020 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that the company sold its shares in the capital of the subsidiary “Aromania” AD.

Sofia, Bulgaria, December 23, 2020 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that the Board of Directors gave a mandate to the Executive director and the Procurator of the company to negotiate for the sale of the shares owned by “Sopharma” AD in its subsidiaries “Veta Pharma” AD and “Aromania” AD.